| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |